Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT1 | P30419 | 7/20 | 0.46 |
| ▸ | NMT2 | O60551 | 6/20 | 0.46 |
| ▸ | TLR2 | O60603 | 1/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16380851 | 0.91 | TLR2 (0.47) | NMT1NMT2TLR2 | |
| SCHEMBL21664308 | 0.91 | TLR2 (0.47) | NMT1NMT2TLR2 | |
| SCHEMBL15349361 | 0.90 | DPP8 (0.48) | DPP8DPP9DPP7UTS2RGSR | |
| SCHEMBL21779007 | 0.90 | TLR2 (0.49) | NMT1NMT2TLR2 | |
| SCHEMBL31325363 | 0.86 | DPP8 (0.49) | TLR2DPP8DPP9DPP7GSR | |
| SCHEMBL31614336 | 0.86 | DPP8 (0.49) | NMT1NMT2TLR2DPP8DPP9 | |
| SCHEMBL29740503 | 0.86 | DPP8 (0.49) | TLR2DPP8DPP9DPP7GSR | |
| SCHEMBL29462129 | 0.86 | DPP8 (0.49) | TLR2DPP8DPP9DPP7GSR | |
| SCHEMBL8510167 | 0.86 | DPP7 (0.47) | DPP8DPP9DPP7UTS2RGSR | |
| SCHEMBL29805332 | 0.86 | DPP8 (0.49) | TLR2DPP8DPP9DPP7GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111269312-B | Heterologous fusion protein | 鲁南制药集团股份有限公司 | 2023-05-09 | — | — | CN | disclosed |